Posts in category Business Standard
O2C segment may drive RIL’s Q4FY23 revenue; retail, telco stable: Analysts (20-04-2023)
RIL Q4 preview: Analysts expect steady improvement across all segments of Reliance Industries in Q4FY23, with stronger base gross refining margins, and reduced impact of windfall tax
Emkay Global zooms 20% on Sebi’s in-principle nod to enter MF business (20-04-2023)
The company said it has received in-principle approval from Securities and Exchange Board of India, Investment Management Department for sponsoring a Mutual Fund
Indian money managers continue to trim holdings of Adani Group’s stocks (20-04-2023)
Investments by local equity mutual funds in the group accounted for only 0.9% of the industry's $182 billion in assets at the end of March
ITC m-cap hits Rs 5-trn for the first time; stock surges 21% so far in CY23 (20-04-2023)
ITC is expected to maintain its volume growth momentum in the cigarette business, given no price hikes in the near term and government curbing illicit cigarette sales
Gold price rises by Rs 230 to Rs 61,150, silver up by Rs 200 to Rs 77,600 (20-04-2023)
The price of ten grams of 22-carat gold rose Rs 200 to Rs 56,050
Stocks to Watch: Tata Motors, HCL Tech, Ultratech, NBCC, Mastek, Tata Comm (20-04-2023)
Stocks to Watch today: Jaguar Land Rover, the luxury automotive subsidiary of Tata Motors, said it will invest £15 billion (Rs 1.53 lakh crore) over the next five years for an electric-first future
Stock Market LIVE: Sensex, Nifty volatile; pharma stocks decline, PSUs gain (20-04-2023)
Stock market LIVE updates: Infosys, RIL, Bajaj Finance, HCL Tech, Axis Bank, and HUL weighed on benchmarks
Can the rally in Nifty Realty index sustain? Here’s what charts suggest (20-04-2023)
The Nifty Realty Index could face stiff resistance in the range of 445 to 457 levels.
Markets fall for third day as IT sell-off continues; Sensex dips 159 points (19-04-2023)
The Nifty IT index fell 1.8 per cent on concerns over the growth outlook for the sector amid a slowdown in the US and European markets
Mankind Pharma’s Rs 4,326-crore initial public offering to open April 25 (19-04-2023)
The offering is entirely a secondary share sale by promoters, global private equity firm Cairnhill and some other investors of the firm